These results suggest that CML-derived LTF plays a role in the suppression of a pro-inflammatory response and CD36 expression in BM niche macrophages, ultimately reducing their clearance capacity. This evidence concerns the gene CD36 and chronic myelogenous leukemia, BCR-ABL1 positive.